Providing chronic pain management in the “Fifth Vital Sign” Era: Historical and treatment perspectives on a modern-day medical dilemma DA Tompkins, JG Hobelmann, P Compton Drug and alcohol dependence 173, S11-S21, 2017 | 361 | 2017 |
Report of the American Psychiatric Association task force on treatment of gender identity disorder W Byne, SJ Bradley, E Coleman, AE Eyler, R Green, EJ Menvielle, ... Archives of sexual behavior 41, 759-796, 2012 | 345 | 2012 |
Extended‐release injectable naltrexone for opioid use disorder: a systematic review BP Jarvis, AF Holtyn, S Subramaniam, DA Tompkins, EA Oga, ... Addiction 113 (7), 1188-1209, 2018 | 208 | 2018 |
Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument DA Tompkins, GE Bigelow, JA Harrison, RE Johnson, PJ Fudala, ... Drug and alcohol dependence 105 (1-2), 154-159, 2009 | 181 | 2009 |
Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies C Liao, D Zhang, C Mungo, DA Tompkins, AM Zeidan Gynecologic oncology 135 (1), 163-171, 2014 | 175 | 2014 |
Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon? DA Tompkins, CM Campbell Current pain and headache reports 15, 129-136, 2011 | 146 | 2011 |
Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial TR Kosten, CB Domingo, D Shorter, F Orson, C Green, E Somoza, ... Drug and alcohol dependence 140, 42-47, 2014 | 144 | 2014 |
A hidden aspect of the US opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder AS Huhn, EC Strain, DA Tompkins, KE Dunn Drug and alcohol dependence 193, 142-147, 2018 | 122 | 2018 |
The growing regulation of conversion therapy J Drescher, A Schwartz, F Casoy, CA McIntosh, B Hurley, K Ashley, ... Journal of medical regulation 102 (2), 7-12, 2016 | 121 | 2016 |
Phenotypic screening of mutations in Pmr1, the yeast secretory pathway Ca2+/Mn2+-ATPase, reveals residues critical for ion selectivity and transport Y Wei, J Chen, G Rosas, DA Tompkins, PA Holt, R Rao Journal of Biological Chemistry 275 (31), 23927-23932, 2000 | 91 | 2000 |
Sex differences in measures of central sensitization and pain sensitivity to experimental sleep disruption: implications for sex differences in chronic pain MT Smith Jr, B Remeniuk, PH Finan, TJ Speed, DA Tompkins, ... Sleep 42 (2), zsy209, 2019 | 87 | 2019 |
Hematological adverse events in clozapine-treated children and adolescents G Gerbino-Rosen, D Roofeh, DA Tompkins, D Feryo, L Nusser, ... Journal of the American Academy of Child and Adolescent Psychiatry 44 (10 …, 2005 | 79 | 2005 |
Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients KE Dunn, PH Finan, DA Tompkins, EC Strain Addictive behaviors 76, 8-14, 2018 | 73 | 2018 |
Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients KE Dunn, PH Finan, DA Tompkins, M Fingerhood, EC Strain Drug and alcohol dependence 157, 143-149, 2015 | 62 | 2015 |
Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial A Umbricht, A DeFulio, EL Winstanley, DA Tompkins, J Peirce, MZ Mintzer, ... Drug and alcohol dependence 140, 92-100, 2014 | 62 | 2014 |
Efficacy of tramadol extended-release for opioid withdrawal: a randomized clinical trial KE Dunn, DA Tompkins, GE Bigelow, EC Strain JAMA psychiatry 74 (9), 885-893, 2017 | 57 | 2017 |
A Double‐Blind, Placebo‐Controlled Trial Assessing the Efficacy of Levetiracetam Extended‐Release in Very Heavy Drinking Alcohol‐Dependent Patients JB Fertig, ML Ryan, DE Falk, RZ Litten, ME Mattson, J Ransom, ... Alcoholism: Clinical and Experimental Research, 2012 | 54 | 2012 |
The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use AS Huhn, DA Tompkins, KE Dunn Drug and alcohol dependence 180, 279-285, 2017 | 49 | 2017 |
Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients AS Huhn, MM Sweeney, RK Brooner, MS Kidorf, DA Tompkins, H Ayaz, ... Neuropsychopharmacology 44 (4), 826-833, 2019 | 47 | 2019 |
Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial A Bisaga, P Mannelli, M Yu, N Nangia, CE Graham, DA Tompkins, ... Drug and alcohol dependence 187, 171-178, 2018 | 47 | 2018 |